TRCT
DH icon

Tower Research Capital (TRC)’s Definitive Healthcare DH Stock Holding History

Tower Research Capital (TRC)’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.85K Sell
5,841
-6,896
-54% -$6.32K ﹤0.01% 4334
2026
Q1 		$15.7K Buy
12,737
+8,597
+208% +$14.9K ﹤0.01% 3658
2025
Q4 		$11.9K Buy
4,140
+735
+22% +$2.04K ﹤0.01% 3542
2025
Q3 		$13.8K Sell
3,405
-13,828
-80% -$55.2K ﹤0.01% 3650
2025
Q2 		$67.2K Buy
17,233
+13,466
+357% +$42.4K ﹤0.01% 2718
2025
Q1 		$10.9K Buy
3,767
+3,560
+1,720% +$14.4K ﹤0.01% 3598
2024
Q4 		$851 Sell
207
-2,320
-92% -$10.1K ﹤0.01% 5150
2024
Q3 		$11.3K Sell
2,527
-3,123
-55% -$14.7K ﹤0.01% 3673
2024
Q2 		$30.8K Buy
5,650
+4,459
+374% +$28.1K ﹤0.01% 3471
2024
Q1 		$9.61K Sell
1,191
-4,595
-79% -$40.6K ﹤0.01% 3824
2023
Q4 		$57.5K Buy
5,786
+4,959
+600% +$38.9K ﹤0.01% 3035
2023
Q3 		$6.61K Sell
827
-1,278
-61% -$12.8K ﹤0.01% 4579
2023
Q2 		$23.2K Sell
2,105
-18,917
-90% -$195K ﹤0.01% 3252
2023
Q1 		$218K Buy
21,022
+15,888
+309% +$187K 0.01% 1321
2022
Q4 		$57K Sell
5,134
-576
-10% -$7.41K ﹤0.01% 2251
2022
Q3 		$89K Buy
5,710
+3,943
+223% +$86.7K ﹤0.01% 2657
2022
Q2 		$41K Sell
1,767
-1,391
-44% -$29.8K ﹤0.01% 3078
2022
Q1 		$78K Buy
3,158
+1,453
+85% +$32.8K ﹤0.01% 2384
2021
Q4 		$47K Sell
1,705
-8,226
-83% -$288K ﹤0.01% 2806
2021
Q3 		$426K Buy
+9,931
New +$441K 0.01% 1109

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Tower Research Capital (TRC)'s DH Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Definitive Healthcare (DH) stake by 54% in Q2 2026, selling an estimated $6.32K and leaving 5,841 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #4334.

Tower Research Capital (TRC) first reported a position in DH in Q3 2021 and has held it in 20 quarters since. The position peaked at $426K in Q3 2021. 99 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Tower Research Capital (TRC) held 5,841 shares of Definitive Healthcare worth $4.85K as of Q2 2026.
  • Tower Research Capital (TRC) sold 6,896 Definitive Healthcare shares in Q2 2026, an estimated $6.32K.
  • Definitive Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4334 holding.
  • Tower Research Capital (TRC) first reported a position in Definitive Healthcare in Q3 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Definitive Healthcare position peaked at $426K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.